Companies & Industry »Company News
Glaxosmithkline Pharmaceuticals Ltd - Company News

BSE   22 Jun 18 | 12:00 AM

2801.00 19.4 (0.7%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 500660
Face Value: 10

NSE   22 Jun 18 | 12:00 AM

2808.90 23.05 (0.83%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 2,800.75 (0.01%)
1 Month : Rs 2,350.75 (19.15%)
1 Year : Rs 2,464.75 (13.64%)
change companytradenow

  • 01 Sep 16
    12:14 AM
    Pharma major GlaxoSmithKline Pharmaceuticals has revived its plans to sell 60 acre land parcel in Thane, on the outskirts of Mumbai, almost after two years. The company invited bids for its land parcel recently, said a source.
  • 28 Jul 16
    04:22 PM
    GlaxoSmithKline Pharmaceuticals on Thursday reported a 23.12% fall in standalone net profit at Rs 72.27 crore for the June quarter, on account of increase in expenditure.
  • 31 Jul 15
    03:28 PM
    GlaxoSmithKline Pharmaceuticals today reported 5.09 per cent decline in its net profit at Rs 93.28 crore for the first quarter ended June 30, hit by supply constraints.
  • 02 Dec 14
    01:53 PM
    Shares of select pharmaceutical companies Sun Pharma Advanced Research Company (SPARC), Wockhardt, GlaxoSmithKline Pharmaceuticals, Indoco Remedies and Natco Pharma have rallied between 5-10% on back of heavy volumes in otherwise subdued market on BSE.
  • 21 Sep 14
    12:04 AM
    On Friday morning, China woke up to news that homegrown e-commerce giant Alibaba had raised $21.8 billion in its initial public offering - the largest by any company in the US.
  • 19 Aug 14
    05:35 AM
    GSK Pharmaceuticals has been underperforming peers for the last few quarters and this does not look likely to change if the June quarter results are anything to go by.
  • 01 Aug 14
    06:04 PM
    Health food drink major GlaxoSmithKline Consumer Healthcare is planning to expand its reach in the country by penetrating the rural markets and adding one million more stores to its existing network of around 2.7 million stores in next 18 months.
  • 24 Apr 14
    12:50 AM
    The multi-billion dollar three-way deal of Novartis with GlaxoSmithKline (GSK) and Eli Lilly is likely to trigger merger control approvals from various anti-trust authorities, including a scrutiny by Competition Commission of India (CCI), industry
  • 23 Apr 14
    12:58 AM
    Swiss drug major Novartis’ multi-billion-dollar overhaul through deals with two multinational firms — GlaxoSmithKline (GSK) and Eli Lilly — is likely to have an impact on the Indian market, too, as all the three companies have
    12:47 AM
    GlaxoSmithKline's $1-billion open offer to raise stake in its Indian arm, GlaxoSmithKline Pharmaceuticals, had received a shot in the arm from foreign institutional investors (FII), shareholding data for the March quarter showed.
  • 18 Apr 14
    12:02 AM
    GlaxoSmithKline Pharmaceuticals today posted 42.87% decline in its net profit at Rs 96.54 crore for the first quarter ended March 31, 2014, as the company continued to be impacted by the revamped price control order.
Widgets Magazine


Company Price Gain (%)
Sun Pharma.Inds.576.303.91
M & M908.152.78
H D F C1,902.402.54
Axis Bank524.652.22
Bharti Airtel374.601.74
Widgets Magazine

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine